Form 4 Tracker
Neumora Therapeutics, Inc.
NMRA

9 insider filings · Latest: May 27, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 9, 2024Oct 9 8:10 PMLenz Robert A.
Proposed Sale
5,563$15.01$83.5K

View →

Sep 18, 2024Sep 18 8:27 PMLenz Robert A.
Proposed Sale
10,676$12.09$129.1K

View →

Sep 17, 2024Sep 17 8:37 PMLenz Robert A.
Proposed Sale
30,788$11.81$363.7K

View →

Sep 12, 2024Sep 12 9:18 PMLenz Robert A.
Proposed Sale
32,948$11.43$376.7K

View →

Aug 22, 2024Aug 22 1:48 PMPinto Joshua
Proposed Sale
100,000$11.90$1.2M

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 27, 2026May 29 8:34 PMKristina BurowDirector, 10% Owner
Grant/Award
80,000$1.8680,000(D)

View →

May 27, 2026May 29 8:30 PMMatthew K FustDirector
Grant/Award
80,000$1.8680,000(D)

View →

May 27, 2026May 29 8:22 PMDavid PiacquadDirector
Grant/Award
80,000$1.8680,000(D)

View →

May 27, 2026May 29 8:21 PMAlaa HalawaDirector
Grant/Award
80,000$1.8680,000(D)

View →

May 27, 2026May 29 8:21 PMMaykin HoDirector
Grant/Award
80,000$1.8680,000(D)

View →